Fas kit tab for vaginal itching, vaginitis

Reading File

Finding Sources

Searching the Web

Faskit tablet vaginal itching vaginitis composition uses

Finding Sources

Reading File

I now have all the information needed for a thorough answer.

Fas-3 Kit (FAS Kit) - For Vaginal Discharge / Vaginitis

What Is It?

Fas-3 Kit (also written Faskit or FAS-3) is a combination oral tablet kit made by Hetero Healthcare Limited, used for the syndromic treatment of vaginal discharge - meaning it covers multiple possible causes at once without waiting for lab confirmation.

Composition

Drug	Dose	Class
Fluconazole	150 mg	Antifungal (azole)
Azithromycin	1000 mg (1 g)	Antibiotic (macrolide)
Secnidazole	1000 mg (1 g)	Antiprotozoal / antibacterial (nitroimidazole)

All three tablets are taken orally as a single dose.

How Each Component Works

Fluconazole 150 mg - Disrupts the fungal cell membrane by inhibiting ergosterol synthesis. Covers Candida (yeast infection), the cause of white, curdy discharge and intense vaginal itching.
Secnidazole 1 g - A second-generation nitroimidazole. It damages the DNA of anaerobic organisms and protozoa. Covers:
- Bacterial vaginosis (BV) - caused by Gardnerella vaginalis and anaerobes (fishy-smelling, grey adherent discharge)
- Trichomoniasis (TV) - caused by Trichomonas vaginalis (green/frothy discharge with itch) Note: Park's Textbook recommends Secnidazole 2 g for the standard syndromic protocol - the kit uses 1 g, so confirm the dose with the prescribing physician.
Azithromycin 1 g - Inhibits bacterial protein synthesis (50S ribosome). Covers cervical co-infections:
- Chlamydia trachomatis
- Acts as adjunct against some other bacterial causes

What It Treats (Syndromic Approach)

The syndromic management strategy treats all likely pathogens at once when lab testing is unavailable. The Fas-3 Kit targets the three most common causes of vaginal infection simultaneously:

Cause	Organism	Drug in Kit
Vulvovaginal candidiasis	Candida albicans	Fluconazole
Bacterial vaginosis	Gardnerella, anaerobes	Secnidazole
Trichomoniasis	Trichomonas vaginalis	Secnidazole
Cervical infection (Chlamydia)	Chlamydia trachomatis	Azithromycin

Dosage

One-time single oral dose - all three tablets taken together, preferably with or after food.
Complete the full kit even if symptoms improve early.

Common Side Effects

Nausea, vomiting, stomach pain
Diarrhea, indigestion, loss of appetite
Headache, dizziness
Altered/metallic taste (from secnidazole)
Temporary worsening of vaginal itching (transient)

To reduce nausea from secnidazole, a metoclopramide tablet may be given 30 minutes before (as recommended in Park's syndromic protocol).

Important Cautions

Alcohol - Avoid alcohol completely with secnidazole (disulfiram-like reaction - flushing, vomiting, palpitations). Avoid for at least 24-48 hours after the dose.
Pregnancy - Fluconazole is contraindicated in the first trimester. Secnidazole should be avoided in pregnancy. Use local/topical agents only in the first trimester. Consult a doctor.
Drug interactions - Azithromycin can prolong the QT interval; caution with other QT-prolonging drugs.
Breastfeeding - Use with caution; consult a doctor.
Do not self-medicate - an accurate diagnosis guides the right treatment. Overuse of antibiotics/antifungals can cause resistance and worsen the condition.

When to See a Doctor Instead

No improvement after 7 days
Symptoms recur frequently
Pelvic pain or fever (possible pelvic inflammatory disease)
Pregnancy or suspicion of pregnancy
Underlying diabetes or HIV (these increase infection recurrence)

Sources: Park's Textbook of Preventive and Social Medicine (Syndromic Management of Vaginal Discharge, p.383); 1mg Fas-3 Kit monograph; PharmEasy FAS-3 Combikit

Is tranex advised in pt taking ecosprin

Reading File

Finding Sources

Searching the Web

tranexamic acid ecosprin aspirin drug interaction contraindication

Finding Sources

Reading Web Page

tranexamic acid aspirin interaction thrombosis risk

Finding Sources

Reading File

Excellent - I now have comprehensive information to give a thorough answer.

Tranexamic Acid (Tranex) in a Patient on Ecosprin (Aspirin)

Short Answer

There is no direct pharmacokinetic drug-drug interaction between tranexamic acid and aspirin - they do not affect each other's metabolism or plasma levels. However, the key concern is clinical context and the underlying condition for which the patient is on aspirin, because tranexamic acid carries a prothrombotic risk that is especially dangerous in patients who have a history of or are at risk for thromboembolism (the very reason most patients are prescribed Ecosprin).

Mechanisms - Why They Oppose Each Other

Drug	Mechanism	Net Effect
Ecosprin (Aspirin)	Irreversibly inhibits COX-1 in platelets → blocks TXA2 → reduces platelet aggregation	Antithrombotic / antiplatelet
Tranexamic acid (Tranex)	Lysine analogue - competes for lysine-binding sites on plasminogen and plasmin → blocks conversion of plasminogen to plasmin → inhibits fibrinolysis (clot breakdown)	Antifibrinolytic / pro-clot stabilizing

They work at different steps of hemostasis and do not neutralize each other pharmacologically. But clinically, using an antifibrinolytic on top of an antiplatelet agent that is already managing a thrombotic risk creates an additive prothrombotic state.

Goodman & Gilman's Pharmacological Basis of Therapeutics, p.740

The Real Concern: Why Ecosprin Patients Are a High-Risk Group

Patients prescribed Ecosprin are typically on it for:

Coronary artery disease / post-MI / post-stent (antiplatelet therapy)
Ischemic stroke / TIA prevention
Peripheral artery disease
Atrial fibrillation (sometimes combined with anticoagulants)
Pre-eclampsia prophylaxis in pregnancy

All of these are active thromboembolic conditions or high-risk states. Tranexamic acid is contraindicated in:

Patients with active intravascular clotting
Active thromboembolic disease
History or risk of thrombosis or thromboembolism (including retinal vein/artery occlusion, DVT, PE, stroke)

If a patient is on Ecosprin for any of the above indications, prescribing tranexamic acid would go against the contraindication label of tranexamic acid itself. The FDA label explicitly states: "Avoid concomitant use of Tranexamic Acid and medical products that are pro-thrombotic, as the risk of thrombosis may be increased."

When Tranex May Still Be Used Despite Aspirin

There are specific, limited scenarios where tranexamic acid is used alongside aspirin:

Perioperative/surgical bleeding - Many orthopedic studies (hip/knee arthroplasty, cardiac surgery) use tranexamic acid in patients on antiplatelet agents. Goodman & Gilman's notes: "There appears to be little or no increased risk of thrombosis" in surgical patients given TXA - but this is under controlled settings with close monitoring.
Heavy menstrual bleeding (menorrhagia) - Oral TXA 1 g four times daily for 4 days. If the patient is on low-dose aspirin for a minor indication (e.g., primary prevention), the risk-benefit may still favor TXA for menorrhagia - but must be evaluated individually.
Trauma / massive hemorrhage - IV TXA within 3 hours of injury is given regardless of antiplatelet therapy because the hemorrhagic risk outweighs thrombotic risk.

Practical Clinical Decision

Patient's Reason for Ecosprin	Tranex Advised?
Post-MI / coronary stent / ACS	Generally NO - high thrombotic risk; TXA contraindicated
Ischemic stroke / TIA	Generally NO - contraindicated (cerebrovascular disease)
Menorrhagia (low-dose aspirin, primary prevention)	Caution - individualize; risk-benefit may allow it
Major surgery / trauma with active hemorrhage	Yes - hemorrhage risk outweighs thrombotic risk, but stop aspirin if possible peri-op
Pregnancy (pre-eclampsia prophylaxis + PPH)	Special case - consult obstetrician

Summary

No direct pharmacokinetic interaction between tranexamic acid and aspirin.
The clinical concern is prothrombotic additive risk - TXA is contraindicated in patients with any history/risk of thromboembolism, which is the primary reason most patients are on Ecosprin.
In high-cardiovascular-risk patients (post-MI, post-stent, stroke), Tranex should generally be avoided unless there is a compelling hemorrhagic indication where benefit clearly outweighs risk.
Always assess the indication for Ecosprin before prescribing Tranex, and consider stopping aspirin temporarily if feasible in elective surgical settings.

This is a shared conversation. Sign in to Orris to start your own chat.